Références

Information sur le cancer / Cancer 101 / Recherche sur le cancer / Diagnostic et pronostic

American Association for Cancer Research (AACR). (2017). AACR Cancer Progress Report 2017. Extrait de: http://www.cancerprogressreport.org/Documents/AACR_CPR17_Final.pdf.

Burstein HJ, Krilov L, Aragon-Ching JB, et al. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. American Society of Clinical Oncology (ASCO). (2017, April 20). Journal of Clinical Oncology. 35(12):1341-1367. Extrait de: https://www.asco.org/sites/new-www.asco.org/files/content-files/research-and-progress/documents/2017-cca-report.pdf.

Tomosynthesis (3D Mammography) for breast cancer screening. Canadian Agency for Drugs and Technologies in Health (CADTH). (2015, May). Issues in Emerging Health Technologies. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Extrait de: https://www.cadth.ca/sites/default/files/pdf/EH0026_Tomosynthesis_Breast_Cancer_Screening_e.pdf.

Canadian Cancer Research Alliance. (2015, September). TARGET 2020: A Strategy for Collaborative Action 2015-2020.

Canadian Cancer Research Alliance. (2010, May). Pan-Canadian Cancer Research Strategy: A Plan for Collaborative Action by Canada's Cancer Research Funders.

Davidson NE, Armstrong SA, Coussens LM, et al. AACR cancer progress report 2016. (2016). Clinical Cancer Research. 22(19 Supplement):S1-S137. Extrait de: http://cancerprogressreport.org/2016/Documents/CPR2016.pdf.

Dawson SJ, Tsui DW, Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. (2013, March 28). New England Journal of Medicine. 368(13):1199-209.

Lippman SM. What is the latest in preventing cancer?. (2016, January 7). Cancer Research Catalyst. American Association for Cancer Research. Extrait de: http://blog.aacr.org/what-is-the-latest-in-preventing-cancer/.

National Cancer Institute. (2015, March 13). Research – Diagnosis. Extrait de: http://www.cancer.gov/research/areas/diagnosis.

National Cancer Institute. (2010, January 26). The Downside of Diagnostic Imaging. Extrait de: http://www.cancer.gov/about-cancer/diagnosis-staging/research/downside-diagnostic-imaging.

National Cancer Institute. (2016, November 30). Cancer Biology Research. Extrait de: https://www.cancer.gov/research/areas/biology.

National Cancer Institute. (2017, March 9). Cancer Screening and Early Detection Research. Extrait de: https://www.cancer.gov/research/areas/screening.

National Cancer Institute. (2016, December 22). Molecular and Nuclear Imaging (PET and SPECT). Extrait de: https://imaging.cancer.gov/imaging_basics/cancer_imaging/nuclear_imaging.htm.

Sherman ME, Troester MA, Hoadley KA, Anderson WF. Morphological and molecular classification of human cancer. Thun MJ (ed.). (2018). Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. (4th Édition). New York, NY: Oxford University Press. 3: 19-41.

Zill OA, Mortimer S, Banks KC, et al. Somatic genomic landscape of over 15,000 patients with advanced-stage cancer from clinical next-generation sequencing analysis of circulating tumor DNA. (2016). ASCO 2016 Annual Meeting. Alexandria, VA: American Society of Clinical Oncology. Abstract LBA11501.

×
×